Genomic Uracil Homeostasis during Normal B Cell Maturation and Loss of This Balance during B Cell Cancer Development

REFERENCES

• Bransteitter R, Pham P, Scharff MD, Goodman MF. 2003. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. U. S. A. 100:4102–4107. http://dx.doi.org/10.1073/pnas.0730835100.
   PubMed Web of Science ®Google Scholar
• Chaudhuri J, Tian M, Khuong C, Chua K, Pinaud E, Alt FW. 2003. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422:726–730. http://dx.doi.org/10.1038/nature01574.
   PubMed Web of Science ®Google Scholar
• Dickerson SK, Market E, Besmer E, Papavasiliou FN. 2003. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197:1291–1296. http://dx.doi.org/10.1084/jem.20030481.
   PubMed Web of Science ®Google Scholar
• Sohail A, Klapacz J, Samaranayake M, Ullah A, Bhagwat AS. 2003. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31:2990–2994. http://dx.doi.org/10.1093/nar/gkg464.
   PubMed Web of Science ®Google Scholar
• Di Noia JM, Neuberger MS. 2007. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76:1–22. http://dx.doi.org/10.1146/annurev.biochem.76.061705.090740.
   PubMed Web of Science ®Google Scholar
• Samaranayake M, Bujnicki JM, Carpenter M, Bhagwat AS. 2006. Evaluation of molecular models for the affinity maturation of antibodies: roles of cytosine deamination by AID and DNA repair. Chem. Rev. 106:700–719. http://dx.doi.org/10.1021/cr040496t.
   PubMedGoogle Scholar
• Stavnezer J, Guikema JE, Schrader CE. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26:261–292. http://dx.doi.org/10.1146/annurev.immunol.26.021607.090248.
   PubMed Web of Science ®Google Scholar
• Yamane A, Resch W, Kuo N, Kuchen S, Li Z, Sun HW, Robbiani DF, McBride K, Nussenzweig MC, Casellas R. 2011. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 12:62–69. http://dx.doi.org/10.1038/ni.1964.
   PubMed Web of Science ®Google Scholar
• Bemark M, Neuberger MS. 2000. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line. Oncogene 19:3404–3410. http://dx.doi.org/10.1038/sj.onc.1203686.
   PubMedGoogle Scholar
• Liu M, Duke JL, Richter DJ, Vinuesa CG, Goodnow CC, Kleinstein SH, Schatz DG. 2008. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451:841–845. http://dx.doi.org/10.1038/nature06547.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L, Chaganti RS, Klein U, Kuppers R, Rajewsky K, Dalla-Favera R. 1998. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. U. S. A. 95:11816–11821. http://dx.doi.org/10.1073/pnas.95.20.11816.
   PubMed Web of Science ®Google Scholar
• Shen HM, Peters A, Baron B, Zhu X, Storb U. 1998. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750–1752. http://dx.doi.org/10.1126/science.280.5370.1750.
   PubMed Web of Science ®Google Scholar
• Petersen-Mahrt SK, Harris RS, Neuberger MS. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418:99–103. http://dx.doi.org/10.1038/nature00862.
   PubMed Web of Science ®Google Scholar
• Poltoratsky V, Goodman MF, Scharff MD. 2000. Error-prone candidates vie for somatic mutation. J. Exp. Med. 192:F27–F30. http://dx.doi.org/10.1084/jem.192.10.F27.
   PubMed Web of Science ®Google Scholar
• Nilsen H, Rosewell I, Robins P, Skjelbred CF, Andersen S, Slupphaug G, Daly G, Krokan HE, Lindahl T, Barnes DE. 2000. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Mol. Cell 5:1059–1065. http://dx.doi.org/10.1016/S1097-2765(00)80271-3.
   PubMed Web of Science ®Google Scholar
• Di Noia JM, Williams GT, Chan DT, Buerstedde JM, Baldwin GS, Neuberger MS. 2007. Dependence of antibody gene diversification on uracil excision. J. Exp. Med. 204:3209–3219. http://dx.doi.org/10.1084/jem.20071768.
   PubMedGoogle Scholar
• Winter DB, Phung QH, Umar A, Baker SM, Tarone RE, Tanaka K, Liskay RM, Kunkel TA, Bohr VA, Gearhart PJ. 1998. Altered spectra of hypermutation in antibodies from mice deficient for the DNA mismatch repair protein PMS2. Proc. Natl. Acad. Sci. U. S. A. 95:6953–6958. http://dx.doi.org/10.1073/pnas.95.12.6953.
   PubMedGoogle Scholar
• Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T. 2003. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197:1173–1181. http://dx.doi.org/10.1084/jem.20030275.
   PubMed Web of Science ®Google Scholar
• Lossos IS, Levy R, Alizadeh AA. 2004. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia 18:1775–1779. http://dx.doi.org/10.1038/sj.leu.2403488.
   PubMed Web of Science ®Google Scholar
• Pasqualucci L, Guglielmino R, Houldsworth J, Mohr J, Aoufouchi S, Polakiewicz R, Chaganti RS, Dalla-Favera R. 2004. Expression of the AID protein in normal and neoplastic B cells. Blood 104:3318–3325. http://dx.doi.org/10.1182/blood-2004-04-1558.
   PubMed Web of Science ®Google Scholar
• Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M, Honjo T, Nussenzweig A, Nussenzweig MC. 2004. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118:431–438. http://dx.doi.org/10.1016/j.cell.2004.08.006.
   PubMed Web of Science ®Google Scholar
• Robbiani DF, Bothmer A, Callen E, Reina-San-Martin B, Dorsett Y, Difilippantonio S, Bolland DJ, Chen HT, Corcoran AE, Nussenzweig A, Nussenzweig MC. 2008. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135:1028–1038. http://dx.doi.org/10.1016/j.cell.2008.09.062.
   PubMed Web of Science ®Google Scholar
• Andersen S, Ericsson M, Dai HY, Pena-Diaz J, Slupphaug G, Nilsen H, Aarset H, Krokan HE. 2005. Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase deficient mice. DNA Repair 4:1432–1441. http://dx.doi.org/10.1016/j.dnarep.2005.08.004.
   PubMedGoogle Scholar
• Robbiani DF, Nussenzweig MC. 2013. Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. Annu. Rev. Pathol. 8:79–103. http://dx.doi.org/10.1146/annurev-pathol-020712-164004.
   PubMed Web of Science ®Google Scholar
• Maul RW, Saribasak H, Martomo SA, McClure RL, Yang W, Vaisman A, Gramlich HS, Schatz DG, Woodgate R, Wilson DMIII, Gearhart PJ. 2011. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nat. Immunol. 12:70–76. http://dx.doi.org/10.1038/ni.1970.
   PubMed Web of Science ®Google Scholar
• Roche B, Claes A, Rougeon F. 2010. Deoxyuridine triphosphate incorporation during somatic hypermutation of mouse VkOx genes after immunization with phenyloxazolone. J. Immunol. 185:4777–4782. http://dx.doi.org/10.4049/jimmunol.1001459.
   PubMedGoogle Scholar
• Chiarle R, Zhang Y, Frock RL, Lewis SM, Molinie B, Ho YJ, Myers DR, Choi VW, Compagno M, Malkin DJ, Neuberg D, Monti S, Giallourakis CC, Gostissa M, Alt FW. 2011. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 147:107–119. http://dx.doi.org/10.1016/j.cell.2011.07.049.
   PubMed Web of Science ®Google Scholar
• Klein IA, Resch W, Jankovic M, Oliveira T, Yamane A, Nakahashi H, Di Virgilio M, Bothmer A, Nussenzweig A, Robbiani DF, Casellas R, Nussenzweig MC. 2011. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147:95–106. http://dx.doi.org/10.1016/j.cell.2011.07.048.
   PubMed Web of Science ®Google Scholar
• Zhang W, Bardwell PD, Woo CJ, Poltoratsky V, Scharff MD, Martin A. 2001. Clonal instability of V region hypermutation in the Ramos Burkitt's lymphoma cell line. Int. Immunol. 13:1175–1184. http://dx.doi.org/10.1093/intimm/13.9.1175.
   PubMedGoogle Scholar
• Kubo K, Ide H, Wallace SS, Kow YW. 1992. A novel, sensitive, and specific assay for abasic sites, the most commonly produced DNA lesion. Biochemistry 31:3703–3708. http://dx.doi.org/10.1021/bi00129a020.
   PubMed Web of Science ®Google Scholar
• Ide H, Akamatsu K, Kimura Y, Michiue K, Makino K, Asaeda A, Takamori Y, Kubo K. 1993. Synthesis and damage specificity of a novel probe for the detection of abasic sites in DNA. Biochemistry 32:8276–8283. http://dx.doi.org/10.1021/bi00083a031.
   PubMed Web of Science ®Google Scholar
• Cabelof DC, Nakamura J, Heydari AR. 2006. A sensitive biochemical assay for the detection of uracil. Environ. Mol. Mutagen. 47:31–37. http://dx.doi.org/10.1002/em.20165.
   PubMedGoogle Scholar
• Lari SU, Chen CY, Vertessy BG, Morre J, Bennett SE. 2006. Quantitative determination of uracil residues in Escherichia coli DNA: contribution of ung, dug, and dut genes to uracil avoidance. DNA Repair 5:1407–1420. http://dx.doi.org/10.1016/j.dnarep.2006.06.009.
   PubMedGoogle Scholar
• Parisien R, Bhagwat AS. 2009. Studying antibody maturation using techniques for detecting uracils in DNA, p 127–143. In Grosjean H (ed), DNA and RNA modification enzymes: comparative structure, mechanism, functions, cellular interactions and evolution. Landes Bioscience, Austin, TX.
   Google Scholar
• Unniraman S, Schatz DG. 2007. Strand-biased spreading of mutations during somatic hypermutation. Science 317:1227–1230. http://dx.doi.org/10.1126/science.1145065.
   PubMed Web of Science ®Google Scholar
• Doseth B, Visnes T, Wallenius A, Ericsson I, Sarno A, Pettersen HS, Flatberg A, Catterall T, Slupphaug G, Krokan HE, Kavli B. 2011. Uracil-DNA glycosylase in base excision repair and adaptive immunity: species differences between man and mouse. J. Biol. Chem. 286:16669–16680. http://dx.doi.org/10.1074/jbc.M111.230052.
   PubMedGoogle Scholar
• Fritz EL, Rosenberg BR, Lay K, Mihailovic A, Tuschl T, Papavasiliou FN. 2013. A comprehensive analysis of the effects of the deaminase AID on the transcriptome and methylome of activated B cells. Nat. Immunol. 14:749–755. http://dx.doi.org/10.1038/ni.2616.
   PubMedGoogle Scholar
• Dingler FA, Kemmerich K, Neuberger MS, Rada C. 27 May 2014. Uracil excision by endogenous SMUG1 glycosylase promotes efficient Ig class switching and impacts on A:T substitutions during somatic mutation. Eur. J. Immunol. http://dx.doi.org/10.1002/eji.201444482.
   Google Scholar
• Nakamura M, Kondo S, Sugai M, Nazarea M, Imamura S, Honjo T. 1996. High frequency class switching of an IgM+ B lymphoma clone CH12F3 to IgA+ cells. Int. Immunol. 8:193–201. http://dx.doi.org/10.1093/intimm/8.2.193.
   PubMed Web of Science ®Google Scholar
• Seitz V, Hummel M, Walter J, Stein H. 2003. Evolution of classic Hodgkin lymphoma in correlation to changes in the lymphoid organ structure of vertebrates. Dev. Comp. Immunol. 27:43–53. http://dx.doi.org/10.1016/S0145-305X(02)00042-3.
   PubMed Web of Science ®Google Scholar
• Greiner A, Tobollik S, Buettner M, Jungnickel B, Herrmann K, Kremmer E, Niedobitek G. 2005. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J. Pathol. 205:541–547. http://dx.doi.org/10.1002/path.1746.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646–674. http://dx.doi.org/10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, Scharff MD. 2002. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415:802–806. http://dx.doi.org/10.1038/nature714.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW. 2008. WHO classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon, France.
   Google Scholar
• Heintel D, Kroemer E, Kienle D, Schwarzinger I, Gleiss A, Schwarzmeier J, Marculescu R, Le T, Mannhalter C, Gaiger A, Stilgenbauer S, Döhner H, Fonatsch C, Jäger U, German CLL Study Group. 2004. High expression of activation-induced cytidine deaminase (AID) mRNA is associated with unmutated IGVH gene status and unfavourable cytogenetic aberrations in patients with chronic lymphocytic leukaemia. Leukemia 18:756–762. http://dx.doi.org/10.1038/sj.leu.2403294.
   PubMed Web of Science ®Google Scholar
• Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, Payelle-Brogard B, Pritsch O, Dighiero G. 2003. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood 101:4029–4032. http://dx.doi.org/10.1182/blood-2002-10-3175.
   PubMed Web of Science ®Google Scholar
• Kim N, Jinks-Robertson S. 2009. dUTP incorporation into genomic DNA is linked to transcription in yeast. Nature 459:1150–1153. http://dx.doi.org/10.1038/nature08033.
   PubMed Web of Science ®Google Scholar
• Galashevskaya A, Sarno A, Vagbo CB, Aas PA, Hagen L, Slupphaug G, Krokan HE. 2013. A robust, sensitive assay for genomic uracil determination by LC/MS/MS reveals lower levels than previously reported. DNA Repair 12:699–706. http://dx.doi.org/10.1016/j.dnarep.2013.05.002.
   PubMedGoogle Scholar
• Mashiyama ST, Hansen CM, Roitman E, Sarmiento S, Leklem JE, Shultz TD, Ames BN. 2008. An assay for uracil in human DNA at baseline: effect of marginal vitamin B6 deficiency. Anal. Biochem. 372:21–31. http://dx.doi.org/10.1016/j.ab.2007.08.034.
   PubMedGoogle Scholar
• Li G, Zan H, Xu Z, Casali P. 2 May 2013. Epigenetics of the antibody response. Trends Immunol. http://dx.doi.org/10.1016/j.it.2013.03.006.
   Google Scholar
• Storb U. 2014. Why does somatic hypermutation by AID require transcription of its target genes? Adv. Immunol. 122:253–277. http://dx.doi.org/10.1016/B978-0-12-800267-4.00007-9.
   PubMed Web of Science ®Google Scholar
• Zan H, White CA, Thomas LM, Mai T, Li G, Xu Z, Zhang J, Casali P. 2012. Rev1 recruits ung to switch regions and enhances du glycosylation for immunoglobulin class switch DNA recombination. Cell Rep. 2:1220–1232. http://dx.doi.org/10.1016/j.celrep.2012.09.029.
   PubMed Web of Science ®Google Scholar
• An Q, Robins P, Lindahl T, Barnes DE. 2005. C –> T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases. EMBO J. 24:2205–2213. http://dx.doi.org/10.1038/sj.emboj.7600689.
   PubMed Web of Science ®Google Scholar
• Nilsen H, Stamp G, Andersen S, Hrivnak G, Krokan HE, Lindahl T, Barnes DE. 2003. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 22:5381–5386. http://dx.doi.org/10.1038/sj.onc.1206860.
   PubMedGoogle Scholar
• Loeffler M, Kreuz M, Haake A, Hasenclever D, Trautmann H, Arnold C, Winter K, Koch K, Klapper W, Scholtysik R, Rosolowski M, Hoffmann S, Ammerpohl O, Szczepanowski M, Herrmann D, Küppers R, Pott C, Siebert R. 16 July 2014. Genomic and epigenomic co-evolution in follicular lymphomas. Leukemia http://dx.doi.org/10.1038/leu.2014.209.
   Google Scholar
• Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Borresen-Dale AL, Boyault S, Burkhardt B, Butler AP, Caldas C, Davies HR, Desmedt C, Eils R, Eyfjord JE, Foekens JA, Greaves M, Hosoda F, Hutter B, Ilicic T, Imbeaud S, Imielinsk M, Jager N, Jones DT, Jones D, Knappskog S, Kool M, Lakhani SR, Lopez-Otin C, Martin S, Munshi NC, Nakamura H, Northcott PA, Pajic M, Papaemmanuil E, Paradiso A, Pearson JV, Puente XS, Raine K, Ramakrishna M, Richardson AL, Richter J, Rosenstiel P, Schlesner M, Schumacher TN, Span PN, Teague JW, et al. 2013. Signatures of mutational processes in human cancer. Nature 500:415–421. http://dx.doi.org/10.1038/nature12477.
   PubMed Web of Science ®Google Scholar
• Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, Menzies A, Martin S, Leung K, Chen L, Leroy C, Ramakrishna M, Rance R, Lau KW, Mudie LJ, Varela I, McBride DJ, Bignell GR, Cooke SL, Shlien A, Gamble J, Whitmore I, Maddison M, Tarpey PS, Davies HR, Papaemmanuil E, Stephens PJ, McLaren S, Butler AP, Teague JW, Jonsson G, Garber JE, Silver D, Miron P, Fatima A, Boyault S, Langerod A, Tutt A, Martens JW, Aparicio SA, Borg A, Salomon AV, Thomas G, Borresen-Dale AL, Richardson AL, Neuberger MS, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149:979–993. http://dx.doi.org/10.1016/j.cell.2012.04.024.
   PubMed Web of Science ®Google Scholar
• Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, Harris S, Shah RR, Resnick MA, Getz G, Gordenin DA. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45:970–976. http://dx.doi.org/10.1038/ng.2702.
   PubMed Web of Science ®Google Scholar
• Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, Yee D, Temiz NA, Donohue DE, McDougle RM, Brown WL, Law EK, Harris RS. 2013. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494:366–370. http://dx.doi.org/10.1038/nature11881.
   PubMed Web of Science ®Google Scholar